Cyfuse Biomedical K.K. (TYO:4892)
Japan flag Japan · Delayed Price · Currency is JPY
492.00
-11.00 (-2.19%)
Nov 18, 2026, 10:25 AM JST

Cyfuse Biomedical K.K. Revenue

Cyfuse Biomedical K.K. had revenue of 10.00M JPY in the quarter ending September 30, 2026, a decrease of -68.75%. This brings the company's total for the last twelve months to 283.00M, up 217.98% year-over-year. In the year 2025, Cyfuse Biomedical K.K. had annual revenue of 230.00M with 325.93% growth. That makes Cyfuse Biomedical K.K. the 42,508th largest company in the world by revenue and 3,853rd in Japan.

Revenue (ttm)
283.00M
Revenue Growth
+217.98%
P/S Ratio
17.71
Revenue / Employee
12.30M
Employees
23
Market Cap
4.90B

Revenue Chart

Revenue by Segment

By Segment

  • Regenerative Medicine 36.68M 67.4%
  • Device 13.22M 24.3%
  • Drug Discovery Support 4.55M 8.3%

By Geography

  • Japan 54.15M 99.5%
  • United States 295.00K 0.5%
Fiscal year ended Dec 31, 2024 See the full Cyfuse Biomedical K.K. breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025230.00M176.00M325.93%
Dec 31, 202454.00M-7.00M-11.48%
Dec 31, 202361.00M-313.00M-83.69%
Dec 31, 2022374.00M-334.00M-47.18%
Dec 31, 2021708.00M571.00M416.79%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CellSource3.67B
Soiken Holdings3.24B
MEDINET998.00M
OncoTherapy Science712.00M
SUSMED,Inc.679.00M
Chiome Bioscience615.15M
Kringle Pharma442.00M
CellSeed161.00M
Revenue Rankings